about
Interaction between Mean Arterial Pressure and HbA1c in Prediction of Cardiovascular Disease Hospitalisation: A Population-Based Case-Control StudyBioengineering Strategies for the Treatment of Type I Diabetes.Effects of microRNA-346 on epithelial-mesenchymal transition in mouse podocytes.Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center.The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method.Association between lung capacity and abnormal glucose metabolism: findings from China and Australia.miR-15a-5p suppresses inflammation and fibrosis of peritoneal mesothelial cells induced by peritoneal dialysis via targeting VEGFAAnti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus ErythematosusChemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathyPrediction of the outcome of antenatal hydronephrosis: significance of urinary EGFValsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathyAcute pancreatitis as initial manifestation in an adult patient with focal proliferative necrotizing purpura nephritisUrinary Emmprin, matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 as potential biomarkers in children with ureteropelvic junction narrowing on conservative treatmentComparison between adults and children with Henoch-Schönlein purpura nephritisUrinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathyElevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathySingle Nucleotide Polymorphisms in PPARD Associated with Systemic Lupus Erythematosus in Chinese Populations
P50
Q37039378-EB2A4AE5-509F-4288-86BF-04EE7311205FQ38865056-9B0A23F4-C121-4A2F-9C6C-2B0D3B1CF20EQ41465684-31B3D7EB-AEBA-4AEF-9C3D-0ABCA5D1CD47Q43468721-020EFEBE-8937-47E1-8003-521E08B2C32DQ47845726-0C42276C-B28D-49A3-97E5-D993B79E5DD2Q48894183-E2D1560C-770A-4063-991A-F3A6BECCA77BQ58544638-7121AEB4-33B9-457F-9D04-789DF7D633C3Q58549171-BA3938BF-C470-4BE8-B6C1-3B1D9FD0D10CQ64235066-B11F1177-B254-418D-9CA4-0E8A0C84E163Q84543574-CF988553-9A88-4BCB-82DF-80B01AC014A9Q85892890-726BF61E-EE2D-40DE-8721-62BC1A8C36EFQ85979543-AD22E524-91FC-47B4-94DB-7DFC89D2ED46Q86177071-E5878B9C-43C4-47F4-B775-595FF3FBBE45Q86200505-1C553EB7-4AAA-4C4E-8C5E-1E6426C04AE6Q87018280-0326F1FE-C43D-420C-AEFF-D3D17B22F11FQ90308021-209F1B53-B2B7-4BA8-A36E-67312D935AF0Q96608752-2AC1757B-C710-45DD-AF96-815FC6DA1EF5
P50
description
investigador
@es
researcher
@en
name
Zhanzheng Zhao
@en
type
label
Zhanzheng Zhao
@en
prefLabel
Zhanzheng Zhao
@en
P31
P496
0000-0001-6079-1631